OpenVSafe by OpenVAERS
Search V-safe

AT3-31089-14964

2 vaccinations 7 coded responses 23 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
020 / MA
Registered
2021-01-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-31
    Dose 1 — Moderna
  2. 2021-01-01
    Registered in v-safe
  3. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site reaction — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Contracted Deltoid muscle @ injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  5. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  6. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Swelling · None
    Adult check-in
  7. 2021-01-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Flushing, Hot flush — Feeling: Good · Fatigue or tiredness
    Free text: Hot flashes, facial flushing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Good · Joint pains
    Adult check-in
  10. 2021-01-14
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling — Feeling: Good
    Free text: One week post vaccination I developed acute moderate swelling of the vaccination injection site including erythema and fluid filled swelling associated with severe itching that lasted for approximately four days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-21
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-26
    Dose 2 — Moderna
  13. 2021-01-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pyrexia — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Ongoing fever
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Paraesthesia — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Very brief paresthesia in left hand
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  17. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  18. 2021-02-02
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  19. 2021-02-09
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-02-16
    Survey response — day 21, dose 2
    MedDRA: Hot flush, Hyperhidrosis — Feeling: Fair
    Free text: Extreme hot flashes and sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-23
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-27
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-01-27
    Survey response — 12 months, dose 2
    MedDRA: Anhedonia, Blood pressure decreased, Decreased appetite, Dizziness, Exercise tolerance decreased, Fatigue, Hypogeusia, Hyposmia, Muscle atrophy, Weight decreased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Very Muted/Very diminished sense of taste and smell, decreased appetite, weight loss, fatigue, anhedonia, autonomic symptoms as well such As dizziness/ lightheadedness, drop in blood pressure upon standing, exercise intolerance, muscle loss.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-01-27
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-01-31
  29. 2022-01-31
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Moderna
22021-01-26Moderna

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Contracted Deltoid muscle @ injection site

2021-01-05

Systemic reaction (other): Hot flashes, facial flushing

Release 2 — day 14, dose 1

2021-01-14

Symptoms: One week post vaccination I developed acute moderate swelling of the vaccination injection site including erythema and fluid filled swelling associated with severe itching that lasted for approximately four days.

Release 3 — days 1–6 daily, dose 2

2021-01-28

Systemic reaction (other): Ongoing fever

2021-01-30

Systemic reaction (other): Very brief paresthesia in left hand

Release 4 — day 21, dose 2

2021-02-16

Symptoms: Extreme hot flashes and sweating

Release 11 — 12 months, dose 2

2022-01-27

Symptoms: Very Muted/Very diminished sense of taste and smell, decreased appetite, weight loss, fatigue, anhedonia, autonomic symptoms as well such As dizziness/ lightheadedness, drop in blood pressure upon standing, exercise intolerance, muscle loss.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnhedonia · · ✓
SDBlood pressure decreased · · ✓
SDDecreased appetite · · ✓
SDDizziness · · ✓
SDExercise tolerance decreased · · ✓
SDFatigue · · ✓
SDHot flush ✓ ✓ ✓
SDHyperhidrosis ✓ ✓ ✓
SDHypogeusia · · ✓
SDHyposmia · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDMuscle atrophy · · ✓
SDWeight decreased · · ✓
SROFlushing ✓ ✓ ✓
SROHot flush ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release